In non-cancer tissues like adipocytes, RAGE is involved in inflammation-dependent Ins resistance, a condition characterized by a reduced ability of Ins to activate IR/IRS1/AKT signaling [51]; in these contexts, the inhibition or ablation of RAGE restores Ins sensitivity and glucose homeostasis [51]. This evidence concerns the gene IRS1 and cancer.